Sang Kim, MD

Yale University
Branford, Connecticut, United States

Sang Kim, MD, PhD, is the Director of the Immunotherapy Adverse Events in Rheumatology Program at Yale University School of Medicine. He is a physician-scientist with a focus on rheumatology and human translational immunology. His research aims to understand the role of immune checkpoint receptors in normal physiology, autoimmune disorders, and cancer.

Presentation(s):

• Checkpoint Molecules and Pathogenesis of Autoimmune Disease

  Saturday, October 25, 2025
  9:00 AM - 9:30 AM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose

• 0273: Effector CD8+ T cells and PD-1hi CXCL13hi CD4+ T cells contribute to recurrent immune checkpoint inhibitor mediated inflammatory arthritis

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure information not submitted.

• 0869: PD-1 inhibitor unleashes pathogenic CD8+ T cells and induce arthritis in collagen-primed mice

  Monday, October 27, 2025
  10:30 AM - 10:45 AM Central Time

  Disclosure information not submitted.